← Back to Search

Dermal Filler

Radiesse, Xeomin, Belotero for Solar Elastosis

Phase 4
Waitlist Available
Led By Eric Bernstein, MD
Research Sponsored by Main Line Center for Laser Surgery
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This study is evaluating whether a combination of treatments can improve signs of photoaging and subject satisfaction.

Eligible Conditions
  • Solar Elastosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
FACE-Q Subject Satisfaction
Secondary outcome measures
Global Assessment Investigator Scale

Side effects data

From 2014 Phase 4 trial • 250 Patients • NCT02096081
6%
Headache
2%
Facial Asymmetry
1%
Human ehrlichiosis
100%
80%
60%
40%
20%
0%
Study treatment Arm
IncobotulinumtoxinA
OnabotulinumtoxinA

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Treatment with Xeomin, Radiesse, and/or Belotero
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Radiesse, Xeomin, Belotero
2021
Completed Phase 4
~30

Find a Location

Who is running the clinical trial?

Main Line Center for Laser SurgeryLead Sponsor
3 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Solar Elastosis
20 Patients Enrolled for Solar Elastosis
Merz North America, Inc.Industry Sponsor
63 Previous Clinical Trials
8,780 Total Patients Enrolled
Kachiu Lee, MDStudy DirectorMain Line Center for Laser Surgery
2 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Solar Elastosis
20 Patients Enrolled for Solar Elastosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational
Eric Bernstein, MD 2021. "Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05039723.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top